Clinical Trial

Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors

Active, Not Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
The goal of the proposed study is to compare the efficacy of behavioral treatment (BT) to memantine, a psychopharmacological agent, for BFRBs. 28 subjects with trichotillomania (TTM) or skin picking disorder (SPD) will receive 8 weeks of memantine treatment, followed by 8 weeks of comprehensive behavioral therapy (ComB) treatment. The hypothesis to be tested is that behavioral therapy will be associated with superior clinical outcomes as compared to memantine. A second hypothesis is that both memantine and behavioral therapy will demonstrate improvement from baseline to the respective posttreatment assessment.
Protocol Amendment History 2 changes
notable Primary completion moved earlier: 2026-06 -> 2026-04-16 2026-07-08
minor Completion pushed: 2026-06 -> 2027-06 2026-07-08
Trial Details
NCT Number NCT05796752
Lead Sponsor University of Chicago
Conditions Skin-Picking, Trichotillomania (Hair-Pulling Disorder)
Enrollment 26 participants
Start Date 2023-08-02
Primary Completion 2026-04-16 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-07